Target intelligence / Profile preview

General cellular metabolic pathways

Molecular classification
Enzyme, Transporter, Receptor, Transcription factor
01

Overview

General cellular metabolic pathways encompass the vast network of biochemical reactions that sustain life by converting nutrients into energy and biosynthetic precursors. These processes are broadly categorized into catabolism, which breaks down molecules like glucose and lipids to produce ATP, and anabolism, which utilizes that energy to construct cellular components such as proteins and nucleic acids (StatPearls, 2023). Central pathways include glycolysis, the citric acid cycle, and oxidative phosphorylation, all of which are tightly regulated to maintain cellular homeostasis (NIH, 2022). Dysregulation of these pathways is a hallmark of various pathologies, including metabolic syndrome, diabetes, and cancer, where cells often shift toward aerobic glycolysis to support uncontrolled proliferation (NCBI, 2021). While the term refers to a broad system rather than a single protein, many specific enzymes and transporters within these pathways serve as primary targets for pharmacological intervention. For example, drugs like metformin and statins modulate metabolic flux to treat systemic diseases, while antimetabolites are used in oncology to disrupt the synthesis of essential metabolites (PubMed, 2020).

Other names
Cellular metabolismIntermediary metabolismMetabolic networkMetabolic processes
02

Mechanism of action

Drugs targeting metabolic pathways typically act by inhibiting rate-limiting enzymes, competing with natural substrates, or modulating the activity of metabolic sensors like AMPK or mTOR to restore homeostasis or selectively kill pathological cells (PubMed, 2022).

03

Biological functions

Energy productionBiosynthesisRedox homeostasisCell growthHomeostasis
04

Disease associations

CancerDiabetes mellitusMetabolic syndromeInborn errors of metabolismCardiovascular disease
05

Safety considerations

Systemic toxicityMetabolic acidosisHypoglycemiaOff-target metabolic disruption
06

Interacting drugs

Metformin

4 more in the full profile.

07

Biomarkers

Blood glucoseLactateHemoglobin A1cLipid profileMetabolomic signatures

Beyond the preview

Go deeper on General cellular metabolic pathways.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on General cellular metabolic pathways.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call